202 related articles for article (PubMed ID: 17599040)
1. Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells.
Goto T; Takano M; Albergaria A; Briese J; Pomeranz KM; Cloke B; Fusi L; Feroze-Zaidi F; Maywald N; Sajin M; Dina RE; Ishihara O; Takeda S; Lam EW; Bamberger AM; Ghaem-Maghami S; Brosens JJ
Oncogene; 2008 Jan; 27(1):9-19. PubMed ID: 17599040
[TBL] [Abstract][Full Text] [Related]
2. The regulation and function of the forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma.
Ward EC; Hoekstra AV; Blok LJ; Hanifi-Moghaddam P; Lurain JR; Singh DK; Buttin BM; Schink JC; Kim JJ
Endocrinology; 2008 Apr; 149(4):1942-50. PubMed ID: 18096667
[TBL] [Abstract][Full Text] [Related]
3. [MiR-135b promotes proliferation of endometrial carcinoma cells by targeting FOXO1].
Yue Z; Shen JJ; Huang QT; Qin YF; Li XN; Liu GB
Nan Fang Yi Ke Da Xue Xue Bao; 2016 May; 36(5):675-80. PubMed ID: 27222184
[TBL] [Abstract][Full Text] [Related]
4. The FOXO1-miR27 tandem regulates myometrial invasion in endometrioid endometrial adenocarcinoma.
Mozos A; Catasús L; D'Angelo E; Serrano E; Espinosa I; Ferrer I; Pons C; Prat J
Hum Pathol; 2014 May; 45(5):942-51. PubMed ID: 24746199
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of FOXO1 mRNA levels predicts treatment failure in patients with endometrial pathology conservatively managed with progestin-containing intrauterine devices.
Reyes HD; Carlson MJ; Devor EJ; Zhang Y; Thiel KW; Samuelson MI; McDonald M; Yang S; Stephan JM; Savage EC; Dai D; Goodheart MJ; Leslie KK
Gynecol Oncol; 2016 Jan; 140(1):152-60. PubMed ID: 26524723
[TBL] [Abstract][Full Text] [Related]
6. Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer.
Myatt SS; Wang J; Monteiro LJ; Christian M; Ho KK; Fusi L; Dina RE; Brosens JJ; Ghaem-Maghami S; Lam EW
Cancer Res; 2010 Jan; 70(1):367-77. PubMed ID: 20028871
[TBL] [Abstract][Full Text] [Related]
7. Metformin inhibits estrogen-dependent endometrial cancer cell growth by activating the AMPK-FOXO1 signal pathway.
Zou J; Hong L; Luo C; Li Z; Zhu Y; Huang T; Zhang Y; Yuan H; Hu Y; Wen T; Zhuang W; Cai B; Zhang X; Huang J; Cheng J
Cancer Sci; 2016 Dec; 107(12):1806-1817. PubMed ID: 27636742
[TBL] [Abstract][Full Text] [Related]
8. Cullin-5, a ubiquitin ligase scaffold protein, is significantly underexpressed in endometrial adenocarcinomas and is a target of miR-182.
Devor EJ; Schickling BM; Reyes HD; Warrier A; Lindsay B; Goodheart MJ; Santillan DA; Leslie KK
Oncol Rep; 2016 Apr; 35(4):2461-5. PubMed ID: 26847831
[TBL] [Abstract][Full Text] [Related]
9. Inhibin-α subunit expression in uterine endometrioid adenocarcinomas and endometrial cancer cell lines: a potential prognostic factor.
Mylonas I
Int J Mol Med; 2011 Mar; 27(3):309-18. PubMed ID: 21174065
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of DNA methyltransferase 3B expression in endometrial cancers.
Jin F; Dowdy SC; Xiong Y; Eberhardt NL; Podratz KC; Jiang SW
Gynecol Oncol; 2005 Feb; 96(2):531-8. PubMed ID: 15661247
[TBL] [Abstract][Full Text] [Related]
11. Chemosensitization of endometrial cancer cells through AKT inhibition involves FOXO1.
Hoekstra AV; Ward EC; Hardt JL; Lurain JR; Singh DK; Buttin BM; Schink JC; Kim JJ
Gynecol Oncol; 2008 Mar; 108(3):609-18. PubMed ID: 18234299
[TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis in endometrial cancer cells by psammaplysene A involves FOXO1.
Berry E; Hardt JL; Clardy J; Lurain JR; Kim JJ
Gynecol Oncol; 2009 Feb; 112(2):331-6. PubMed ID: 19041124
[TBL] [Abstract][Full Text] [Related]
13. The G protein-coupled receptor GPR30 mediates the nontranscriptional effect of estrogen on the activation of PI3K/Akt pathway in endometrial cancer cells.
Ge X; Guo R; Qiao Y; Zhang Y; Lei J; Wang X; Li L; Hu D
Int J Gynecol Cancer; 2013 Jan; 23(1):52-9. PubMed ID: 23235274
[TBL] [Abstract][Full Text] [Related]
14. Roles of SIRT1/FoxO1/SREBP-1 in the development of progestin resistance in endometrial cancer.
Wang Y; Zhang L; Che X; Li W; Liu Z; Jiang J
Arch Gynecol Obstet; 2018 Nov; 298(5):961-969. PubMed ID: 30206735
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of tyrosine threonine kinase inhibits tumor growth via G2/M arrest in human endometrioid endometrial adenocarcinoma.
Zhang J; Jiang Y; Zhao Y; Wang W; Xie Y; Wang H; Yang Y
Tumour Biol; 2017 Jul; 39(7):1010428317712444. PubMed ID: 28718377
[TBL] [Abstract][Full Text] [Related]
16. FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium.
Soufla G; Sifakis S; Spandidos DA
Cancer Lett; 2008 Feb; 259(2):146-55. PubMed ID: 18006148
[TBL] [Abstract][Full Text] [Related]
17. GRP78 mediates cell growth and invasiveness in endometrial cancer.
Calì G; Insabato L; Conza D; Bifulco G; Parrillo L; Mirra P; Fiory F; Miele C; Raciti GA; Di Jeso B; Terrazzano G; Beguinot F; Ulianich L
J Cell Physiol; 2014 Oct; 229(10):1417-26. PubMed ID: 24526410
[TBL] [Abstract][Full Text] [Related]
18. Epithelial to mesenchymal transition in early stage endometrioid endometrial carcinoma.
Montserrat N; Mozos A; Llobet D; Dolcet X; Pons C; de Herreros AG; Matias-Guiu X; Prat J
Hum Pathol; 2012 May; 43(5):632-43. PubMed ID: 21940036
[TBL] [Abstract][Full Text] [Related]
19. LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma.
Marshall AD; van Geldermalsen M; Otte NJ; Anderson LA; Lum T; Vellozzi MA; Zhang BK; Thoeng A; Wang Q; Rasko JE; Holst J
Int J Cancer; 2016 Dec; 139(11):2529-39. PubMed ID: 27486861
[TBL] [Abstract][Full Text] [Related]
20. Functional and clinicopathological analysis of loss of MKK4 expression in endometrial cancer.
Ishikawa M; Nakayama K; Rahman MT; Rahman M; Katagiri A; Iida K; Miyazaki K
Oncology; 2010; 79(3-4):238-46. PubMed ID: 21372598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
